Mersana Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Mersana Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2018 to Q3 2024.
  • Mersana Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 295 %, a 18.2% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 295 -65.8 -18.2% Sep 30, 2024
Q2 2024 332 -21.9 -6.19% Jun 30, 2024
Q1 2024 365 +25.4 +7.48% Mar 31, 2024
Q4 2023 360 +3.55 +1% Dec 31, 2023
Q3 2023 361 -4.92 -1.34% Sep 30, 2023
Q2 2023 354 -41.1 -10.4% Jun 30, 2023
Q1 2023 340 -118 -25.9% Mar 31, 2023
Q4 2022 356 -155 -30.4% Dec 31, 2022
Q3 2022 366 -252 -40.8% Sep 30, 2022
Q2 2022 395 -395 -50% Jun 30, 2022
Q1 2022 458 -520 -53.2% Mar 31, 2022
Q4 2021 511 -487 -48.8% Dec 31, 2021
Q3 2021 618 -266 -30.1% Sep 30, 2021
Q2 2021 790 +105 +15.4% Jun 30, 2021
Q1 2021 978 +491 +101% Mar 31, 2021
Q4 2020 999 +473 +90% Dec 31, 2020
Q3 2020 884 +550 +165% Sep 30, 2020
Q2 2020 685 +388 +131% Jun 30, 2020
Q1 2020 487 +225 +85.6% Mar 31, 2020
Q4 2019 526 +293 +125% Dec 31, 2019
Q3 2019 334 -4.39 -1.3% Sep 30, 2019
Q2 2019 297 -101 -25.4% Jun 30, 2019
Q1 2019 262 -118 -30.9% Mar 31, 2019
Q4 2018 233 Dec 31, 2018
Q3 2018 338 Sep 30, 2018
Q2 2018 398 Jun 30, 2018
Q1 2018 380 Mar 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.